Pediatric urologist develops procedure to eliminate scarring in kidney surgeries

Surgery and all its implications can be scary, especially so for pediatric patients and their parents who dread sometimes disfiguring scars.

Now a UT Southwestern Medical Center urologist has developed a new "hidden" minimally that makes scarring virtually invisible yet is just as effective as more common surgical methods.

"Currently used incisions, even with minimally , leave the child with up to three scars that are visible any time the abdomen is exposed. The new technique of hidden incision endoscopic surgery (HIdES) eliminates visible scarring," said Dr. Patricio Gargollo, assistant professor of urology at UT Southwestern and author of a study in a recent issue of the .

He reports using the procedure for a dozen kidney surgery cases between April and July 2010 with no complications, but believes it has broader applications.

"I envision that this could be used for any upper abdominal procedure that needs to be done laparoscopically, and I currently perform all upper abdominal and some pelvic surgery with this technique," said Dr. Gargollo, who is also director of minimally invasive and at Children's Medical Center of Dallas.

HIdES was named the Best New Technique Award at the International Robotic Urology Symposium in 2010.

Minimally such as laparoscopy are often used in kidney surgeries. They leave much less scarring than , which requires a large incision across the patient's abdomen. But laparoscopic surgery, in which a tiny camera inserted through a small incision acts as the surgeon's "eyes," still leaves noticeable scars, Dr. Gargollo said.

In addition to its cosmetic benefits, the HIdES technique offers surgeons greater technical flexibility than laparoscopic surgery because it uses multiple surgical ports for robotic-assisted surgical equipment and a camera. These ports are hidden below the bikini line, making them invisible if the patient is wearing a bathing suit.

Patients old enough to answer a survey, including older teenagers, and parents of younger children showed greater satisfaction with the HIdES incision scars than those generated by laparoscopic and open surgery, the study reported.

add to favorites email to friend print save as pdf

Related Stories

Magnetic system could be key to surgery without scars

Mar 26, 2007

Physicians at UT Southwestern Medical Center and engineers at UT Arlington have collaborated to invent a groundbreaking system that could be key to delivering on the promise of surgery without scars.

Recommended for you

Hormonal therapy for transsexualism safe and effective

23 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...